Given the similar activity of HIV integrase inhibitors to the RAG1/2 system, which is critical to B and T cell maturation, HAART regimens containing integrase inhibitors merit particular attention and further investigation as a potential novel mechanism in the development of possible IRIS-related NHL in patients with depressed immunity. Here, RAG1 is linked to non-Hodgkin lymphoma.